IN2015DN01414A - - Google Patents

Info

Publication number
IN2015DN01414A
IN2015DN01414A IN1414DEN2015A IN2015DN01414A IN 2015DN01414 A IN2015DN01414 A IN 2015DN01414A IN 1414DEN2015 A IN1414DEN2015 A IN 1414DEN2015A IN 2015DN01414 A IN2015DN01414 A IN 2015DN01414A
Authority
IN
India
Prior art keywords
present
dabigatran etexilate
isolation
require
formula
Prior art date
Application number
Other languages
English (en)
Inventor
Sudhir Singh Sanwal
Anandam Vempali
Balaguru Murugesan
Swargam Sathyanarayana
Rajesh Kumar Thaper
Mohan Prasad
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to IN1414DEN2015 priority Critical patent/IN2015DN01414A/en
Publication of IN2015DN01414A publication Critical patent/IN2015DN01414A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IN1414DEN2015 2012-08-31 2013-09-02 IN2015DN01414A (enrdf_load_stackoverflow)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN1414DEN2015 IN2015DN01414A (enrdf_load_stackoverflow) 2012-08-31 2013-09-02

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2712DE2012 2012-08-31
PCT/IB2013/058232 WO2014033693A1 (en) 2012-08-31 2013-09-02 Process for the preparation of crystalline form i of methanesulfonate salt of dabigatran etexilate
IN1414DEN2015 IN2015DN01414A (enrdf_load_stackoverflow) 2012-08-31 2013-09-02

Publications (1)

Publication Number Publication Date
IN2015DN01414A true IN2015DN01414A (enrdf_load_stackoverflow) 2015-07-03

Family

ID=49301574

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1414DEN2015 IN2015DN01414A (enrdf_load_stackoverflow) 2012-08-31 2013-09-02

Country Status (5)

Country Link
US (1) US9150542B2 (enrdf_load_stackoverflow)
EP (1) EP2890692A1 (enrdf_load_stackoverflow)
CA (1) CA2881947A1 (enrdf_load_stackoverflow)
IN (1) IN2015DN01414A (enrdf_load_stackoverflow)
WO (1) WO2014033693A1 (enrdf_load_stackoverflow)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104725360A (zh) * 2015-04-09 2015-06-24 重庆东得医药科技有限公司 一种甲磺酸达比加群酯ⅰ晶型的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087380A (en) 1949-11-24 2000-07-11 Boehringer Ingelheim Pharma Kg Disubstituted bicyclic heterocycles, the preparations and the use thereof as pharmaceutical compositions
DE10339862A1 (de) 2003-08-29 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)- phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester-Methansulfonat und dessen Verwendung als Arzneimittel
DE102005025728A1 (de) 2005-06-04 2006-12-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Polymorphe von 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-Propionsäure-ethylester
DE102005061623A1 (de) * 2005-12-21 2007-06-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verbessertes Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen und deren Salzen
DE102005061624A1 (de) 2005-12-21 2007-06-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verbessertes Verfahren zur Herstellung von Salzen von 4-(Benzimidazolylmethylamino)-Benzamidinen
DE102006054005A1 (de) 2006-11-16 2008-05-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Polymorphe von 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester
WO2011110478A1 (en) 2010-03-08 2011-09-15 Ratiopharm Gmbh Dabigatran etexilate-containing pharmaceutical composition
WO2012027543A1 (en) 2010-08-25 2012-03-01 Teva Pharmaceuticals Usa, Inc. Solid state forms of dabigatran etexilate, dabigatran etexilate mesylate and processes for preparation thereof
WO2012077136A2 (en) 2010-12-06 2012-06-14 Msn Laboratories Limited Process for the preparation of benzimidazole derivatives and its salts

Also Published As

Publication number Publication date
EP2890692A1 (en) 2015-07-08
WO2014033693A1 (en) 2014-03-06
CA2881947A1 (en) 2014-03-06
US9150542B2 (en) 2015-10-06
US20150197504A1 (en) 2015-07-16

Similar Documents

Publication Publication Date Title
PH12016500169A1 (en) Polymorph of syk inhibitors
MX361653B (es) Procedimiento para la preparación de derivados del ácido biliar.
IL227648B (en) Process for preparing 4-amino-5-fluoro-3-halo-6-(converted) picolinates
IL227646A0 (en) Process for preparing 4-amino-3-chloro-5-fluoro-6-(converted) picolinates
IL227647B (en) Process for preparing 4-amino-5-fluoro-3-halo-6-(converted) picolinates
WO2013111163A3 (en) Process for the preparation of dabigatran etexilate mesylate and polymorphs of intermediates thereof
IL227645B (en) Process for preparing 4-amino-3-chloro-5-fluoro-6-(converted) picolinates
EP2758387A4 (en) Pyridine compounds as kinase inhibitors
IN2014DN06964A (enrdf_load_stackoverflow)
IN2015DN02616A (enrdf_load_stackoverflow)
IN2013MU03070A (enrdf_load_stackoverflow)
WO2012140490A3 (en) Processes for preparing pitavastatin calcium
IN2015DN02601A (enrdf_load_stackoverflow)
IN2014DN09451A (enrdf_load_stackoverflow)
MX2016012485A (es) Proceso para preparar 3-(3-(4-(1-aminociclobutil)fenil)-5-fenil-3h -imidazo[4,5-b]piridin-2-il)piridin-2-amina.
MX363944B (es) Método de preparación de los compuestos de ceramidas de alfa-galactosilo.
WO2013072938A3 (en) Process for the preparation of roflumilast
IN2013MU04056A (enrdf_load_stackoverflow)
IN2015DN01414A (enrdf_load_stackoverflow)
IL239228A0 (en) Improved process for the preparation of n-cyano-s-[1-(pyridine-3-yl)ethyl]-s-methylsulfylamines
WO2014170909A3 (en) Process for pomalidomide
WO2014041558A3 (en) Process for preparation of crystalline etoricoxib
MX2014012822A (es) Proceso para elaborar derivados de naftiridina.
IN2013MU01219A (enrdf_load_stackoverflow)
WO2014020546A3 (en) Crystalline forms of dabigatran etexilate and process for their preparation